Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Queensland Health
Baxter
AstraZeneca
Colorcon
Cipla
US Department of Justice
Chubb
UBS

Generated: November 14, 2018

DrugPatentWatch Database Preview

Drugs in Development Information for Lersivirine

« Back to Dashboard

US Patents for Lersivirine

Glossary
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Lersivirine ➤ Sign Up Pyrazole derivatives Agouron Pharmaceuticals, Inc. (La Jolla, CA) ➤ Sign Up
Lersivirine ➤ Sign Up Chemical compounds Pfizer Inc (New York, NY) ➤ Sign Up
Lersivirine ➤ Sign Up Pyrazole derivatives Pfizer Inc (New York, NY) ➤ Sign Up
Lersivirine ➤ Sign Up Purine derivatives Pfizer Limited (Sandwich, Kent, GB) ➤ Sign Up
Lersivirine ➤ Sign Up Pharmaceuticals Pfizer Inc. (New York, NY) ➤ Sign Up
Lersivirine ➤ Sign Up Imidazopyridine substituted tropane derivatives with CCR5 receptor antagonist activity for the treatment of HIV and inflammation Pfizer Inc (New York, NY) ➤ Sign Up
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Lersivirine

Glossary
Drugname Country Document Number Estimated Expiration Related US Patent
Lersivirine African Regional IP Organization (ARIPO) 1846 2021-04-10 ➤ Sign Up
Lersivirine Argentina 037319 2021-04-10 ➤ Sign Up
Lersivirine Argentina 076259 2021-04-10 ➤ Sign Up
Lersivirine Austria 358669 2021-04-10 ➤ Sign Up
Lersivirine Austria 556059 2021-04-10 ➤ Sign Up
Lersivirine Australia 2002242926 2021-04-10 ➤ Sign Up
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Mallinckrodt
Chubb
McKesson
Medtronic
Federal Trade Commission
Citi
Accenture
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
Major Patent Expirations 2018 - 2019
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2018, www.DrugPatentWatch.com.
Links

Follow DrugPatentWatch: